GT200900044A - Polimorfo de bromuro de (r)-3-(2-hidroxi-2,2-difenil-acetoxi)-1-(isoxazol-3-il-carbamoil-metil)-1-azonia-biciclo-[2.2.2]-octano - Google Patents
Polimorfo de bromuro de (r)-3-(2-hidroxi-2,2-difenil-acetoxi)-1-(isoxazol-3-il-carbamoil-metil)-1-azonia-biciclo-[2.2.2]-octanoInfo
- Publication number
- GT200900044A GT200900044A GT200900044A GT200900044A GT200900044A GT 200900044 A GT200900044 A GT 200900044A GT 200900044 A GT200900044 A GT 200900044A GT 200900044 A GT200900044 A GT 200900044A GT 200900044 A GT200900044 A GT 200900044A
- Authority
- GT
- Guatemala
- Prior art keywords
- difenil
- acetoxi
- carbamoil
- hidroxi
- azonia
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Otolaryngology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
UNA FORMA DE CRISTAL POLIMÓRFICO NOVEDOSA DE BROMURO DE (R)-3-(2-HIDROXI-2.2-DIFENIL-ACETOXI)-1-(ISOXAZOL-3-IL-CARBAMOIL-METIL)-1-AZONIA-BICICLO-(2.2.2)-OCTANO, DESIGNADA COMO LA FORMA DEL CRISTAL TALFA. TAMBIÉN SE DESCRIBEN MÉTODOS PARA LA PREPARACIÓN DE LA MISMA, Y EL USO DE LA FORMA DEL CRISTAL COMO EL INGREDIENTE ACTIVO DE MEDICAMENTOS PARA EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS U OBSTRUCTIVAS DE LAS VÍAS RESPIRATORIAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06119883A EP1900737A1 (en) | 2006-08-31 | 2006-08-31 | Polymorph of (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200900044A true GT200900044A (es) | 2012-01-16 |
Family
ID=37685707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200900044A GT200900044A (es) | 2006-08-31 | 2009-02-27 | Polimorfo de bromuro de (r)-3-(2-hidroxi-2,2-difenil-acetoxi)-1-(isoxazol-3-il-carbamoil-metil)-1-azonia-biciclo-[2.2.2]-octano |
Country Status (21)
Country | Link |
---|---|
US (1) | US20090264461A1 (es) |
EP (2) | EP1900737A1 (es) |
JP (1) | JP2010501611A (es) |
KR (1) | KR20090051110A (es) |
CN (1) | CN101506205A (es) |
AR (1) | AR062582A1 (es) |
AU (1) | AU2007291515A1 (es) |
BR (1) | BRPI0716205A2 (es) |
CA (1) | CA2660983A1 (es) |
CL (1) | CL2007002524A1 (es) |
GT (1) | GT200900044A (es) |
IL (1) | IL196808A0 (es) |
MA (1) | MA31412B1 (es) |
MX (1) | MX2009002300A (es) |
NO (1) | NO20091231L (es) |
PE (1) | PE20080985A1 (es) |
RU (1) | RU2009111390A (es) |
TN (1) | TN2009000069A1 (es) |
TW (1) | TW200817399A (es) |
WO (1) | WO2008025541A1 (es) |
ZA (1) | ZA200900449B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR044134A1 (es) * | 2003-05-02 | 2005-08-24 | Novartis Ag | Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas. |
SI2091537T1 (sl) * | 2006-11-23 | 2013-10-30 | Sinoxa Pharma Gmbh | Farmacevtski sestavki za zdravljenje kapilarne arteriopatije |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR044134A1 (es) * | 2003-05-02 | 2005-08-24 | Novartis Ag | Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas. |
-
2006
- 2006-08-31 EP EP06119883A patent/EP1900737A1/en not_active Ceased
-
2007
- 2007-08-28 PE PE2007001164A patent/PE20080985A1/es not_active Application Discontinuation
- 2007-08-29 KR KR1020097006532A patent/KR20090051110A/ko not_active Application Discontinuation
- 2007-08-29 MX MX2009002300A patent/MX2009002300A/es not_active Application Discontinuation
- 2007-08-29 US US12/438,999 patent/US20090264461A1/en not_active Abandoned
- 2007-08-29 BR BRPI0716205-7A2A patent/BRPI0716205A2/pt not_active Application Discontinuation
- 2007-08-29 WO PCT/EP2007/007560 patent/WO2008025541A1/en active Application Filing
- 2007-08-29 CA CA002660983A patent/CA2660983A1/en not_active Abandoned
- 2007-08-29 AR ARP070103830A patent/AR062582A1/es unknown
- 2007-08-29 RU RU2009111390/04A patent/RU2009111390A/ru not_active Application Discontinuation
- 2007-08-29 JP JP2009525978A patent/JP2010501611A/ja active Pending
- 2007-08-29 CN CNA2007800314914A patent/CN101506205A/zh active Pending
- 2007-08-29 EP EP07801981A patent/EP2064210A1/en not_active Withdrawn
- 2007-08-29 AU AU2007291515A patent/AU2007291515A1/en not_active Abandoned
- 2007-08-30 CL CL200702524A patent/CL2007002524A1/es unknown
- 2007-08-30 TW TW096132302A patent/TW200817399A/zh unknown
-
2009
- 2009-01-20 ZA ZA200900449A patent/ZA200900449B/xx unknown
- 2009-01-29 IL IL196808A patent/IL196808A0/en unknown
- 2009-02-27 TN TN2009000069A patent/TN2009000069A1/fr unknown
- 2009-02-27 GT GT200900044A patent/GT200900044A/es unknown
- 2009-03-13 MA MA31715A patent/MA31412B1/fr unknown
- 2009-03-24 NO NO20091231A patent/NO20091231L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20090264461A1 (en) | 2009-10-22 |
KR20090051110A (ko) | 2009-05-20 |
MA31412B1 (fr) | 2010-06-01 |
RU2009111390A (ru) | 2010-10-10 |
WO2008025541A1 (en) | 2008-03-06 |
JP2010501611A (ja) | 2010-01-21 |
CN101506205A (zh) | 2009-08-12 |
EP2064210A1 (en) | 2009-06-03 |
AR062582A1 (es) | 2008-11-19 |
PE20080985A1 (es) | 2008-09-05 |
NO20091231L (no) | 2009-03-25 |
ZA200900449B (en) | 2010-01-27 |
IL196808A0 (en) | 2009-11-18 |
CL2007002524A1 (es) | 2008-07-11 |
AU2007291515A1 (en) | 2008-03-06 |
MX2009002300A (es) | 2009-03-20 |
TN2009000069A1 (en) | 2010-08-19 |
EP1900737A1 (en) | 2008-03-19 |
CA2660983A1 (en) | 2008-03-06 |
BRPI0716205A2 (pt) | 2013-11-12 |
TW200817399A (en) | 2008-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018501807A1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of diseas | |
CL2008003096A1 (es) | Compuestos derivados de piperidino-dihidrotienopirimidinas; inhibidores pde4; composicion farmaceutica que los comprende; y uso en el tratamiento de trastornos o enfermedades de las vias respiratorias o gastrointestinales, como tambien enfermedades inflamatorias de las articulaciones u ojos, entre otras. | |
MX2015016344A (es) | Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades. | |
ECSP10010178A (es) | Derivados bis-(sulfonilamino) en terapia 066 | |
UY30500A1 (es) | Compuestos de azabencimidazolilo | |
UY29506A1 (es) | Nuevas formas cristalinas de bromuro de tiotropio | |
UY30328A1 (es) | Derivados de 2-piridona, procesos de preparacion, composiciones conteniéndolos y aplicaciones. | |
UY31430A1 (es) | Derivados de piridina y pirazina -83 | |
UY32483A (es) | Nuevos compuestos de bencimidazol para el tratamiento del virus sincicial respiratorio | |
LTC1781298I2 (lt) | Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui | |
ECSP11011067A (es) | Compuestos para el tratamiento de enfermedades y desórdenes oftalmológicos | |
UY30327A1 (es) | Nuevos compuestos ii | |
ECSP109889A (es) | Composiciones terapeuticas y usos de las mismas | |
CR20110230A (es) | Inhibidores de las enzimas de proteina cinasa activadas por mitogeno p38 | |
ECSP088511A (es) | Agonistas del receptor del neuropeptido-2 | |
CY1120435T1 (el) | Φαρμακοτεχνικες μορφες που περιλαμβανουν κρυσταλλικες μορφες του μονοενυδρου υδροχλωρικου (r)-7-χλωρο-ν-(κινουκλιδινο-3-υλο) βενζο(β)θειοφαινο-2-καρβοξαμιδιου | |
MX2015016421A (es) | Derivados de pirazolo-pirrolidin-4-ona como inhibidores de bet y su uso en el tratamiento de enfermedades. | |
ECSP066770A (es) | Nuevos ésteres de quinuclidina cuaternizados | |
UY30393A1 (es) | Derivados sustituidos de la 1-piperidin-1-il-1,3-dihidro-2h-benzimidazol-2-ona, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones | |
ECSP10010597A (es) | Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas | |
MX2019004484A (es) | Derivados de naftiridinona y su uso en el tratamiento de la arritmia. | |
UA107702C2 (en) | Novel benzamide derivatives | |
SE0401655D0 (sv) | New compounds | |
EA201691058A1 (ru) | Производные пирролопирролона и их применение для лечения заболеваний | |
GT200900044A (es) | Polimorfo de bromuro de (r)-3-(2-hidroxi-2,2-difenil-acetoxi)-1-(isoxazol-3-il-carbamoil-metil)-1-azonia-biciclo-[2.2.2]-octano |